Relay Therapeutics to Participate in Fireside Chat at Bank of America Securities 2022 Precision Oncology Conference

Rhea-AI Summary

Relay Therapeutics (Nasdaq: RLAY) is set to participate in a virtual fireside chat at the Bank of America Securities 2022 Precision Oncology Conference on October 3, 2022, at 2:50 p.m. ET. The event will be webcast live and can be accessed via Relay Therapeutics’ website. An archived replay will be available for up to 30 days after the presentation. Relay Therapeutics focuses on transforming drug discovery using its Dynamo™ platform, aimed at enhancing small molecule therapeutic discovery in oncology and genetic diseases.

CAMBRIDGE, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, is scheduled to participate in a virtual fireside chat at the Bank of America Securities 2022 Precision Oncology Conference on Monday, October 3, 2022, at 2:50 p.m. ET. The fireside chat will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcast will be available for up to 30 days following the presentation.

About Relay Therapeutics

Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. As the first of a new breed of biotech created at the intersection of disparate technologies, Relay Therapeutics aims to push the boundaries of what’s possible in drug discovery. Its Dynamo™ platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable. Relay Therapeutics’ initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. For more information, please visit www.relaytx.com or follow us on Twitter.

Contact:
Caroline Glen
617-370-8837
cglen@relaytx.com

Media:
Dan Budwick
1AB
973-271-6085
dan@1abmedia.com

FAQ

What date is Relay Therapeutics' virtual fireside chat at the Precision Oncology Conference?

Relay Therapeutics will participate in the virtual fireside chat on October 3, 2022.

What time will the Relay Therapeutics fireside chat start?

The fireside chat is scheduled to start at 2:50 p.m. ET.

How can I access the Relay Therapeutics fireside chat webcast?

The webcast can be accessed through Relay Therapeutics’ website under the Events section.

Will there be a replay available for the Relay Therapeutics fireside chat?

Yes, an archived replay of the webcast will be available for 30 days following the presentation.

What is the focus of Relay Therapeutics' drug discovery efforts?

Relay Therapeutics focuses on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications.